Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Astellas Pharma Inc.    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société ASTELLAS PHARMA INC.
01/14ACTINIUM PHARMACEUTICALS : and Astellas Announce Research Collaboration Focused ..
AQ
01/06ASTELLAS PHARMA INC. : - FDA Accepts for Priority Review the New Drug Applicatio..
AQ
2020ASTELLAS PHARMA : Reports XOSPATA in Combination with Azacitidine Did Not Meet E..
AQ
2020ASTELLAS PHARMA : Supports Recommendations of Task Force on Climate-related Fina..
AQ
2020ASTELLAS PHARMA INC. : - Expansion of the Domestic Logistics Platform for Pharma..
AQ
2020VIATRIS : Astellas and Viatris Announce Termination of Co-promotion, Succession ..
AQ
2020Astellas Receives Approval of EVRENZO in Japan for the Treatment of Anemia of..
AQ
2020ASTELLAS PHARMA : Launches a 'Contact for Potential Acquisition of ' R&D Program..
AQ
2020ASTELLAS PHARMA : to Present New Data on Gilteritinib in FLT3 Mutation-Positive ..
AQ
2020ASTELLAS PHARMA INC. : - XTANDI Approved by China NMPA for the Treatment of Non-..
AQ
2020ASTELLAS PHARMA : Completes Acquisition of iota Biosciences
AQ
2020ASTELLAS PHARMA : Receives U.S. FDA Fast Track Designation for ASP5354, an Inves..
AQ
2020ASTELLAS PHARMA : ITI Announces Promotion of Dr. Tim Coleman to SVP, Operations ..
AQ
2020ASTELLAS PHARMA INC. : - U.S. FDA Grants Fast Track Designation for ASP0367/MA-0..
AQ
2020ASTELLAS PHARMA INC. : - New Roxadustat Data in Anemia of Chronic Kidney Disease..
AQ
2020ASTELLAS PHARMA : China Update – Drug Patents
AQ
2020ASTELLAS PHARMA : to acquire iota Biosciences
AQ
2020ASTELLAS PHARMA : FibroGen to Present New Efficacy and Safety Analyses from Roxa..
AQ
2020ASTELLAS PHARMA : to Acquire iota Biosciences
BU
2020ASTELLAS PHARMA : and Seagen Announce Positive Topline Results from Second Cohor..
AQ
2020ASTELLAS PHARMA : and LabCentral Announce Golden Ticket Winners, Helping Emergin..
AQ
2020ASTELLAS PHARMA : Celebrates First-Ever Virtual Day of Service to Help Non-Profi..
AQ
2020ASTELLAS PHARMA : and MBC BioLabs Announce Golden Ticket Competition to Help Bio..
AQ
2020ASTELLAS PHARMA : Real-World Evidence Studies Provide Further Insight into Negat..
AQ
2020ASTELLAS PHARMA : and University of Pittsburgh Announce Research Collaboration f..
AQ
2020ASTELLAS PHARMA INC. : - Astellas Efforts against the Spread of the Coronavirus ..
AQ
2020ASTELLAS PHARMA : and Seattle Genetics Announce PADCEV Significantly Improved Ov..
AQ
2020ASTELLAS PHARMA : Collaborates with Two Research Centers at the University of To..
AQ
2020ASTELLAS PHARMA : and Seattle Genetics Announce PADCEV Significantly Improved Ov..
PU
2020ASTELLAS PHARMA INC. : - Science-Based Fitness Service, Fit-eNce
AQ
2020ASTELLAS PHARMA : Open Innovation Challenge Astellas Rx+ Healthcare Innovation C..
AQ
2020ASTELLAS PHARMA : is Awarded Grant from the U.S. National Institutes of Health t..
AQ
2020ASTELLAS PHARMA : Named to FTSE4Good Index Series for Ninth Consecutive Year
AQ
2020ASTELLAS PHARMA : Efforts against the Spread of the Coronavirus Disease
AQ
2020ASTELLAS PHARMA : Roxadustat Demonstrates Non-Inferiority to Darbepoetin in Phas..
AQ
2020ASTELLAS PHARMA : City of Yokohama, and Yokohama City University Developed Scien..
AQ
2020ASTELLAS PHARMA : Federal Circuit Reverses PTAB Finding Tarceva® Method Of Treat..
AQ
2020ASTELLAS PHARMA INC. : - FDA Approves VESIcare LS Oral Suspension for Pediatric ..
AQ
2020ASTELLAS PHARMA INC. : - Notice Regarding Continuation of the Performance-linked..
AQ
2020ASTELLAS PHARMA : European Medicines Agency Accepts Astellas Marketing Authoriza..
AQ
2020ASTELLAS PHARMA : Immunomic Therapeutics, Inc. - Maryland's Immunomic Therapeuti..
AQ
2020ASTELLAS PHARMA : Efforts against the Spread of the Coronavirus Disease
AQ
2020ASTELLAS PHARMA : and Harvard Establish Strategic Research Alliance
PU
2020ASTELLAS PHARMA INC. : - Change of Directors and Organizational Change
AQ
2020ASTELLAS PHARMA : Announces Acquisition of Nanna
AQ
2020ASTELLAS PHARMA : Announces Acceptance of XOSPATA for Regulatory Review in China..
AQ
2020ASTELLAS PHARMA : and BANDAI NAMCO Entertainment Enter into Agreement to Co-Deve..
AQ
2020ASTELLAS PHARMA : Three Astellas Research and Production Facilities in Japan Ado..
PU
2020ASTELLAS PHARMA : Launches its Corporate Website's Science Section
PU
2020CytomX Therapeutics and Astellas Announce Strategic Collaboration to Develop ..
AQ
2020ASTELLAS PHARMA : CytomX Therapeutics and Astellas Announce Strategic Collaborat..
PU
2020ASTELLAS PHARMA : Gifu University and Astellas establish a Research Course on Ph..
AQ
2020ASTELLAS PHARMA : Notice Regarding the Performance-linked Stock Compensation Sch..
PU
2020Seattle Genetics and Astellas Receive FDA Breakthrough Therapy Designation fo..
AQ
2020ASTELLAS PHARMA : and Seattle Genetics Receive FDA Breakthrough Therapy Designat..
PU
2020ASTELLAS PHARMA : XTANDI Demonstrates Significant Improvement in Overall Surviva..
AQ
2020SEATTLE GENETICS : and Astellas Announce Updated Results from Phase 1b/2 Trial o..
AQ
2020ASTELLAS PHARMA : Announces Management Structure
AQ
2020ASTELLAS PHARMA : Announces Completion of Acquisition of Own Shares, and Cancell..
PU
2020ASTELLAS PHARMA : Submits Supplemental New Drug Application for Approval of Evre..
AQ
2020ASTELLAS PHARMA : Will Renew Its Corporate Website's Innovation Section
PU
2020ASTELLAS PHARMA : Amgen astellas biopharma to become a wholly owned amgen affili..
PU
2020ASTELLAS PHARMA : Announces Construction of New Manufacturing Facility for Activ..
AQ
2020ASTELLAS PHARMA INC. : - U.S. FDA Approves Supplemental New Drug Application for..
AQ
2020ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares
PU
2019ASTELLAS PHARMA : Strengthens Immuno-oncology Pipeline with Acquisition of Xypho..
AQ
2019ASTELLAS PHARMA : Strengthens Immuno-oncology Pipeline with Acquisition of Xypho..
PU
2019ASTELLAS PHARMA INC. : - FDA Grants Accelerated Approval to Astellas and Seattle..
AQ
2019PFIZER INC. : - XTANDI Approved by U.S. FDA for the Treatment of Metastatic Cast..
AQ
2019ASTELLAS PHARMA : Announces Key Leadership Promotions in Human Resources, Legal
AQ
2019ASTELLAS PHARMA : Presents New Data on XOSPATA in FLT3 Mutation-Positive Relapse..
AQ
2019Seattle Genetics and Astellas Announce Clinical Trial Collaboration with Merc..
AQ
2019ASTELLAS PHARMA : to buy U.S. biotech firm for $3 bil. to boost gene therapy
AQ
2019ASTELLAS PHARMA : ACQUISITION OF AUDENTES - Establishing a leading position in g..
PU
2019ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares
PU
1  2  3  4  5  6  7Next
Upcoming event on ASTELLAS PHARMA INC.